Drug Search Results
More Filters [+]

Barnidipine

Alternative Names: barnidipine
Latest Update: 2022-01-01
Latest Update Note: PubMed Publication

Product Description

Barnidipine is a long-acting novel calcium antagonist that belongs to the dihydropyridine (DHP) group of calcium channel blockers.  (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Barnidipine)

Mechanisms of Action: Calcium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Italy | Korea | Netherlands | Peru | Portugal | Spain | Taiwan | Thailand

Approved Indications: None

Known Adverse Events: None

Company: Astellas Pharma
Company Location: NEW YORK NY 10005
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Barnidipine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hypertension

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ND

P4

Terminated

Hypertension

2007-11-06

ND

P4

Completed

Hypertension

2007-01-30

2005-004288-47

P4

Active, not recruiting

Hypertension

None

Recent News Events